Wave Life Sciences (WVE) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Wave Life Sciences (WVE) over the last 10 years, with Q4 2024 value amounting to $46.3 million.
- Wave Life Sciences' Accumulated Depreciation & Amortization rose 847.6% to $46.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $46.3 million, marking a year-over-year increase of 847.6%. This contributed to the annual value of $46.3 million for FY2024, which is 847.6% up from last year.
- Latest data reveals that Wave Life Sciences reported Accumulated Depreciation & Amortization of $46.3 million as of Q4 2024, which was up 847.6% from $42.7 million recorded in Q4 2023.
- In the past 5 years, Wave Life Sciences' Accumulated Depreciation & Amortization registered a high of $46.3 million during Q4 2024, and its lowest value of $24.9 million during Q4 2020.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $37.8 million (2022), whereas its average is $36.8 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 4640.95% in 2020, then soared by 847.6% in 2024.
- Over the past 5 years, Wave Life Sciences' Accumulated Depreciation & Amortization (Quarter) stood at $24.9 million in 2020, then rose by 29.47% to $32.2 million in 2021, then grew by 17.42% to $37.8 million in 2022, then grew by 12.85% to $42.7 million in 2023, then grew by 8.48% to $46.3 million in 2024.
- Its Accumulated Depreciation & Amortization was $46.3 million in Q4 2024, compared to $42.7 million in Q4 2023 and $37.8 million in Q4 2022.